Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells-Reference-Cited by-同舟云学术

Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells

Published:2018-01-18 Issue:1 Volume:23 Page:201
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Mukherjee Sumit^ORCID,Baidoo Juliet,Sampat Samay,Mancuso Andrew,David Lovena,Cohen Leah,Zhou Shuiqin,Banerjee Probal

Funder

Research Foundation of The City University of New York

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/23/1/201/pdf

Reference66 articles.

1. Analysis of patterns of care of brain tumor patients in the united states: A study of the brain tumor section of the AANS and the CNS and the commission on cancer of the ACS;Mahaley;Clin. Neurosurg.,1990

2. Recent advances in the molecular understanding of glioblastoma

3. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

4. Malignant Gliomas in Adults

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier;Journal of Drug Delivery Science and Technology;2024-09

2. Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies;Cancer Letters;2024-07

3. Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation;EPMA Journal;2024-04-18

4. New Avenues and Major Achievements in Phytocompounds Research for Glioblastoma Therapy;Molecules;2024-04-08

5. Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment;Biomedicine & Pharmacotherapy;2024-02